Guangdong OptoMedic Technologies, Inc. was established in July 2013, and is headquartered in Foshan, Guangdong. It has marketing centers in Beijing and Shanghai, and product research and industrialization centers in Suzhou, Changsha, and Shangrao. OptoMedic focuses on the research and production of high-end medical devices, including full-function endoscopic imaging platforms, fluorescence laparoscopes, white-light laparoscopes, flexible-video endoscopes, single-use endoscopes, energy instruments and platforms, and other products.
As a high-tech company, OptoMedic has won multiple awards for scientific and technological progress and has innovative technology platforms. The 4K Fluorescence Endoscopy System of OptoMedic is leading the industry. OptoMedic was among the earliest Chinese brands to acquire NMPA certification. It also obtained multiple international certifications.
Gathering innovative research strength:OptoMedic has gathered a multidisciplinary talent team composed of PhDs, masters, and other talents from top universities such as Caltech, Tsinghua University, Shanghai Jiao Tong University, Tongji University, Zhejiang University, Huazhong University of Science and Technology, Sun Yat-sen University, Harbin Institute of Technology, and South China University of Technology.
Covering authoritative hospitals nationwide:Currently, OptoMedic’s products have entered more than 500 top-level hospitals in China, including Peking Union Medical College Hospital, West China Hospital of Sichuan University, PLA General Hospital, ZhongShan Hospital Fudan University, the First Affiliated Hospital of Sun Yat-sen University, and Guangdong Provincial People's Hospital, etc.
Highly recognized in the industry:With years of continuous exploration and deep cultivation in the field of high-end medical endoscopes and imaging systems, OptoMedic has gained unanimous recognition in China and overseas. It is the first Chinese brand to enter the core council of the International Society for Fluorescence Guided Surgery (ISFGS), and its endoscopic camera system was honored as top-ranking in the "Fifth Batch of Excellent Domestic Medical Devices" evaluation held by the Chinese National Health Commission's Planning and Information Department.
OptoMedic Founded
Selected for the first Innovation and Entrepreneurship Team in Foshan
Selected for the second "Blue-ocean Talent Plan" Entrepreneurship Team
Awarded "National High-Tech Enterprise"
OptoMedic's multispectral imaging system approved by NMPA
OptoMedic Suzhou founded
Completion of Series A financing
OptoMedic's FHD fluorescence endoscopic imaging system approved by NMPA
Commercialization of dual-camera products
OptoMedic Beijing founded
Completion of Series B financing
Ranked top three in sales in the Chinese market for fluorescence endoscopic imaging systems
Selected as part of the fifth batch of outstanding Chinese medical devices (ranked No. 1 in the rigid endoscope division)
Obtained national intellectual property management system certification
Recognized as a new R&D institution in Guangdong Province
2000 square meters production workshop put into use
Launch of the 4K Fluorescence Endoscopic Imaging System
Recognized as Guangdong Province's Medical 4K Fluorescence Imaging System Engineering Technology Research Center
Initiation of the Flexible-video Endoscope and Development
Completion of Series C financing
Launch of the Modular 4K Endoscopic Platform with Integrated Fluorescence and White Light Functions
Selected for China's Key Research and Development Program by the Ministry of Science and Technology of China
First NMPA certification of the flexible-video Ureteroscope Product
OptoMedic Changsha founded
OptoMedic Shanghai founded
Completion of Series D financing
Launched the Stellar 4K 3D Endoscopic Imaging Platform
Selected for China's Key Research and Development Program by the Ministry of Science and Technology of China
Obtained CE certification
Became the first Chinese Brand to enter the Core Council of the International Society for Fluorescence Guided Surgery (ISFGS)
Completion of Series E and E+ financing
Selected as a "Little Giant" Company in Technology Innovation in China
Received the 24th China Patent Excellence Award
Received the Second Prize of the Guangdong Science and Technology Progress Award
Obtained FDA and CNAS laboratory accreditation
Selected as a Class A Medical Device Manufacturing Company for Quality and Credit in Guangdong Province in 2022
OptoMedic Shangrao founded
Completion of Pre-IPO financing
Received the 25th China Patent Excellence Award
Honored with the 2024 Science and Technology Progress Award by the Chinese Optical Society
The 4K ICG+MB Endoscopic Imaging System was certified and launched on the market
The 3D Fusion Mapping Workstation was certified and launched on the market
The Stellar 4K 3D Endoscopic Imaging Platform received FDA clearance and CE certification
OptoMedic Hong Kong founded
Leading the Future of Endoscopic Surgery
Innovate for a Better Life
Endless Pursuit of Precision